IL93243A - Preparations for the prevention of neurodegeneration - Google Patents
Preparations for the prevention of neurodegenerationInfo
- Publication number
- IL93243A IL93243A IL9324390A IL9324390A IL93243A IL 93243 A IL93243 A IL 93243A IL 9324390 A IL9324390 A IL 9324390A IL 9324390 A IL9324390 A IL 9324390A IL 93243 A IL93243 A IL 93243A
- Authority
- IL
- Israel
- Prior art keywords
- neurodegeneration
- treatment
- prevention
- connection
- chloroethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8900564A SE8900564D0 (sv) | 1989-02-17 | 1989-02-17 | Novel medicinal use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL93243A0 IL93243A0 (en) | 1990-11-29 |
| IL93243A true IL93243A (en) | 1994-08-26 |
Family
ID=20375091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9324390A IL93243A (en) | 1989-02-17 | 1990-02-01 | Preparations for the prevention of neurodegeneration |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0458892B1 (ko) |
| JP (1) | JP3007683B2 (ko) |
| KR (1) | KR0139221B1 (ko) |
| AT (1) | ATE107166T1 (ko) |
| AU (1) | AU643431B2 (ko) |
| CA (1) | CA2045618A1 (ko) |
| DE (1) | DE69009989T2 (ko) |
| DK (1) | DK0458892T3 (ko) |
| ES (1) | ES2055421T3 (ko) |
| HK (1) | HK44597A (ko) |
| IE (1) | IE64622B1 (ko) |
| IL (1) | IL93243A (ko) |
| NZ (1) | NZ232499A (ko) |
| PH (1) | PH26372A (ko) |
| SE (1) | SE8900564D0 (ko) |
| WO (1) | WO1990009174A1 (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP921128B1 (en) * | 1991-10-30 | 1998-10-31 | Sandor Garaczy | Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof |
| SE9802119D0 (sv) * | 1998-06-15 | 1998-06-15 | Astra Ab | New use |
| SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
| SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE196140C1 (ko) * | 1964-01-01 |
-
1989
- 1989-02-17 SE SE8900564A patent/SE8900564D0/xx unknown
-
1990
- 1990-02-01 IL IL9324390A patent/IL93243A/en not_active IP Right Cessation
- 1990-02-09 IE IE46090A patent/IE64622B1/en not_active IP Right Cessation
- 1990-02-12 PH PH40041A patent/PH26372A/en unknown
- 1990-02-13 ES ES90903980T patent/ES2055421T3/es not_active Expired - Lifetime
- 1990-02-13 JP JP2503995A patent/JP3007683B2/ja not_active Expired - Lifetime
- 1990-02-13 AU AU51679/90A patent/AU643431B2/en not_active Ceased
- 1990-02-13 WO PCT/SE1990/000093 patent/WO1990009174A1/en active IP Right Grant
- 1990-02-13 DK DK90903980.2T patent/DK0458892T3/da active
- 1990-02-13 NZ NZ232499A patent/NZ232499A/xx unknown
- 1990-02-13 EP EP90903980A patent/EP0458892B1/en not_active Expired - Lifetime
- 1990-02-13 DE DE69009989T patent/DE69009989T2/de not_active Expired - Lifetime
- 1990-02-13 CA CA002045618A patent/CA2045618A1/en not_active Withdrawn
- 1990-02-13 AT AT90903980T patent/ATE107166T1/de not_active IP Right Cessation
-
1991
- 1991-08-16 KR KR91700916A patent/KR0139221B1/ko not_active IP Right Cessation
-
1997
- 1997-04-10 HK HK44597A patent/HK44597A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0458892B1 (en) | 1994-06-15 |
| NZ232499A (en) | 1992-12-23 |
| KR0139221B1 (en) | 1998-05-15 |
| ATE107166T1 (de) | 1994-07-15 |
| AU5167990A (en) | 1990-09-05 |
| KR920700641A (ko) | 1992-08-10 |
| PH26372A (en) | 1992-06-01 |
| DE69009989T2 (de) | 1994-10-13 |
| ES2055421T3 (es) | 1994-08-16 |
| DK0458892T3 (da) | 1994-08-15 |
| EP0458892A1 (en) | 1991-12-04 |
| IL93243A0 (en) | 1990-11-29 |
| IE900460L (en) | 1990-08-17 |
| JP3007683B2 (ja) | 2000-02-07 |
| WO1990009174A1 (en) | 1990-08-23 |
| SE8900564D0 (sv) | 1989-02-17 |
| HK44597A (en) | 1997-04-18 |
| IE64622B1 (en) | 1995-08-23 |
| AU643431B2 (en) | 1993-11-18 |
| CA2045618A1 (en) | 1990-08-18 |
| DE69009989D1 (de) | 1994-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69713890T3 (de) | Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin-sensitivität erhöht | |
| KR101396731B1 (ko) | 프로스타글란딘 Ｆ２ａ 유도체를 유효 성분으로서 함유하는망막신경세포 보호제 | |
| SK2922002A3 (en) | Use of retigabin for treating neuropathic pain | |
| SK284923B6 (sk) | Zmes liečiv s antidepresívnym účinkom obsahujúca 2-amino-4,5,6,7- tetrahydro-6-propylaminobenzotiazol a sertralín a jej použitie | |
| JPH0637395B2 (ja) | ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤 | |
| JPS5910585A (ja) | スピロスクシンイミド誘導体のアルツハイマ−型痴「ほう」の治療における使用 | |
| Fann et al. | Deanol in tardive dyskinesia: a preliminary report | |
| EP0458892B1 (en) | Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration | |
| JPH0320222A (ja) | 脳内虚血症治療剤 | |
| JPS61286326A (ja) | パ−キンソン病治療薬 | |
| US5399572A (en) | Chlormethiazole in the treatment of neurodegeneration | |
| CZ285633B6 (cs) | Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek | |
| HUT50440A (en) | Process for producing pharmaceutical compositions for treating schizophrenia | |
| EP1121110B1 (en) | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications | |
| JP2549480B2 (ja) | 排尿障害改善剤 | |
| KR100692235B1 (ko) | 안지오텐신 ⅱ 길항물질의 신규한 용도 | |
| EP1410808A1 (en) | Optic nerve protecting agents containing alpha 1 receptor blocker as the active ingredient | |
| CZ287441B6 (en) | Pharmaceutical preparation for treating traumatic lesion of brain | |
| KR20230043905A (ko) | 5-메틸-1,2,4-옥사디아졸-3-일 화합물의 저용량 요법 및 제제 | |
| JPH04503512A (ja) | 新規な医薬用途 | |
| ES2281775T3 (es) | Metodo para tratar insuficiencia renal. | |
| AU2017305661B2 (en) | New use of N,N-bis-2-mercaptoethyl isophthalamide | |
| JPH07507280A (ja) | （−）−メトリフォネート含有薬剤 | |
| US9192602B2 (en) | Indication of anthra[2,1,c][1,2,5]thiadiazole-6,11-dione compound in alleviating pain | |
| CN1200710C (zh) | 大环内酯类化合物的新用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| HC | Change of name of proprietor(s) | ||
| FF | Patent granted | ||
| RH1 | Patent not in force |